| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA5306577 | EUB0002354 | Inhibition | = | 12.5 | % | ALA5304403 | % | Homo sapiens | |||
| 2. |  Bezafibrate | BZF | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 3. | Bezafibrate | BZF | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 4. |  β-Cyclodextrin | beta-cyclodextrin | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 5. | β-Cyclodextrin | beta-cyclodextrin | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 6. |  3,4-Benzopyrene | benzo[a]pyrene (B[a]P) | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 7. | 3,4-Benzopyrene | benzo[a]pyrene (B[a]P) | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 8. |  ALA1201346 | Balsalazide | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 9. | ALA1201346 | Balsalazide | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 10. |  azasetron | SID26751695 | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 11. | azasetron | SID26751695 | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 12. |  Atenolol | 3 | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 13. | Atenolol | 3 | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 14. |  Antipyrine | Antipyrine | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 15. | Antipyrine | Antipyrine | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 16. |  Carbon tetrachloride | 7 | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 17. | Carbon tetrachloride | 7 | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 18. |  Caffeic acid phenethyl ester | CAPE | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 19. | Caffeic acid phenethyl ester | CAPE | IC50 | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens | |||||
| 20. |  bupropion | bupropion | Ki | 0 | ALA1909215 | Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured) | Homo sapiens |
The page will load shortly, Thanks for your patience!